Previous molecular profiling of chemotherapy-resistant breast cancers has identified Ras-ERK pathway activation, degradation of ECM, AKT1 signaling via mTOR, hypoxia, EMT, and angiogenesis as activated pathways related to chemoresistance 15, 16, 18. Here, MTOR is linked to breast cancer.